- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Patient Out-of-Pocket Payments for Oral Oncolytics: Results From a 2009 US Claims Data AnalysisOut-of-pocket payments differ widely among oral oncolytic options. As cost for therapy becomes a greater part of treatment decisions, an understanding of patient out-of-pocket cost will be critical in informing choices.
Latest:
Partnering With Patients to Rapidly Develop a Quality-of-Life Measure in Mycosis Fungoides/Sézary Syndrome Type Cutaneous T-cell LymphomaThe field of measurement in Mycosis Fungoides/Sézary syndrome type cutaneous T-cell lymphoma lacked a specific quality-of-life measure to describe patient experience or guide treatment decisions. Using an online platform with an engaged patient community, we developed and psychometrically validated a new measure in just under a year.
Latest:
Measuring Concurrent Oral Hypoglycemic and Antidepressant Adherence and Clinical OutcomesSelf-reported adherence tended to overestimate medication adherence compared with electronic monitoring. Electronic monitoring of oral hypoglycemic agents but not self-reported adherence predicted glycemic control.
Latest:
Analysis of Venous Thromboprophylaxis Duration and Outcomes in Orthopedic PatientsExtended-duration thromboprophylaxis (>14 days) for total hip replacement/total knee replacement was associated with significantly lower risk for thromboembolic and bleeding events than short-duration thromboprophylaxis.
Latest:
Incorporating Telemedicine as Part of COVID-19 Outbreak Response SystemsHealthcare providers should revisit disaster response policies to incorporate telemedicine systems to address some of the unique challenges posed by infectious disease outbreaks such as coronavirus disease 2019 (COVID-19).
Latest:
Private Sector Risk-Sharing Agreements in the United States: Trends, Barriers, and ProspectsAssessment of current trends, success factors, and challenges in the use of risk-sharing agreements in the US private sector.
Latest:
Telemonitoring With Case Management for Seniors With Heart FailureAn Internet-based telehealth intervention for elderly heart failure patients found no discernible incremental impact on morbidity or mortality compared with case management alone.
Latest:
Identifying Groups of Nonparticipants in Type 2 Diabetes Mellitus EducationThis study describes reasons for nonparticipation in type 2 diabetes mellitus education and identifies typical subgroups of nonparticipants in order to improve recruitment strategies.
Latest:
Relationships Between Provider-Led Health Plans and Quality, Utilization, and SatisfactionThe results of the study demonstrate the potential of provider-led health plans to deliver high-quality care and patient satisfaction. The relationships between these plans and outcomes differed by plan size, nonprofit status, and region.
Latest:
Effect of Management Strategies and Clinical Status on Costs of Care for Advanced HIVAntiretroviral drugs have replaced hospitalization and other services as the most costly component of HIV care, except in patients with especially advanced HIV.
Latest:
Clinical Outcomes and Healthcare Use Associated With Optimal ESRD StartsOptimal end-stage renal disease (ESRD) starts were associated with lower 12-month morbidity, mortality, and inpatient and outpatient utilization in an integrated healthcare delivery system.
Latest:
Preventive Care and Health Behaviors Among Overweight/Obese Men in HMOsHealthcare organizations may reduce weight-related health risks and disparities in care among overweight/obese patients through promoting cancer screening exams, healthier diets, and physical activity.
Latest:
Physician Satisfaction With Health Plans: Results From a National SurveySeveral physician and payer characteristics are associated with physician satisfaction with health plans. There is opportunity to improve physician satisfaction with payers, specifically in pharmacy.
Latest:
COPD Exacerbation Costs in the IMPACT Study: A Within-Trial AnalysisTreatment with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) compared with FF/VI or UMEC/VI reduced exacerbation-related costs associated with chronic obstructive pulmonary disease (COPD) in the US healthcare system.
Latest:
Outcomes Associated With Timing of Maintenance Treatment for COPD ExacerbationEarly initiation of maintenance medication in patients with moderate to severe COPD exacerbations is associated with reduced risk of future exacerbations and lower costs.
